Medifast (MED) – Major News
-
Medifast (MED) Tops Q4 EPS by 19c
-
Medifast (MED) Tops Q3 EPS by 105c
-
Medifast (MED) Tops Q2 EPS by 133c, beats revenue, provides outlook
-
Medifast (MED) Tops Q1 EPS by 41c; Guides Q2 Lower
-
Medifast (MED) Tops Q4 EPS by 148c
-
Medifast (MED) Tops Q2 EPS by 64c; Lowers Outlook
-
Medifast (MED) Tops Q1 EPS by 3c, Offers Guidance
-
Medifast (MED) Tops Q4 EPS by 26c, Offers Guidance
-
Medifast (MED) Tops Q3 EPS by 48c
-
Medifast (MED) Tops Q2 EPS by 65c
-
Medifast (MED) Misses Q4 EPS by 2c
-
Medifast (MED) Tops Q3 EPS by 45c, Revenues Beat
-
Medifast (MED) Tops Q2 EPS by 13c
-
Medifast (MED) Tops Q1 EPS by 23c
-
Medifast (MED) Tops Q4 EPS by 59c, Revenues Beat; Offers Q1 & FY20 EPS/Revenue Guidance Below Consensus
-
Engaged Capital considers bid for Medifast (MED) - Bloomberg
-
Medifast (MED) Misses Q3 EPS by 2c, Q4 Guidance Falls Well Short of Consensus
-
Medifast (MED) Tops Q2 EPS by 3c, Revenues Beat; Raises FY19 EPS/Revenue Guidance
-
Medifast (MED) Tops Q4 EPS by 9c, Revenues Beat; Offers EPS/Revenue Guidance Above Consensus
-
Medifast (MED) Reports In-Line Q3 EPS, Offers Guidance
-
Medifast (MED) Tops Q2 EPS by 16c; Raises Outlook
-
Medifast (MED) Tops Q1 EPS by 15c; Offers FY18 Outlook
-
Medifast (MED) Tops Q4 EPS by 12c, Beats on Revenues; Offers FY18 EPS/Revenues Outlook Above Consensus
-
Medifast (MED) Raises Quarterly Dividend 47.7% to $0.48; 2.9% Yield
-
Medifast (MED) Tops Q3 EPS by 4c
-
Medifast (MED) Tops Q2 EPS by 11c
-
Medifast (MED) Tops Q1 EPS by 4c
-
Medifast (MED) Tops Q4 EPS by 1c
-
Medifast (MED) Tops Q3 EPS by 6c; Boosts FY16 Outlook
-
Medifast (MED) Names Daniel R. Chard as CEO; Company Sees Meeting or Exceeding Q3 Guidance
-
Medifast (MED) Tops Q2 EPS by 12c
-
Medifast (MED) Tops Q1 EPS by 9c; Guides
-
Medifast (MED) Misses Q4 EPS by 2c, Offers Q1 & FY Guidance
-
Medifast (MED) Tops Q3 EPS by 3c; Mixed Outlook
-
Medifast (MED) Reports In-Line Q2 EPS; Issues Mixed Outlook
-
Medifast (MED) Tops Q1 EPS by 1c
-
Medifast (MED) Misses Q4 EPS by 8c, Guidance Mixed
-
Medifast (MED) Tops Q3 EPS by 11c
-
Medifast, Inc. (MED) Tops Q2 EPS by 5c; Guides Lower
-
Medifast, Inc. (MED) Tops Q4 EPS by 3c; Guides Q1 Below the Street
-
Medifast, Inc. (MED) Misses Q3 EPS by 1c
-
Medifast, Inc. (MED) Reports In-Line Q2 EPS
-
Medifast, Inc. (MED) Tops Q1 EPS by 9c; Issues Mixed Outlook
-
Medifast, Inc. (MED) Tops Q4 EPS by 3c; Issues Mixed Outlook
-
Medifast (MED) Can't Keep a CFO; Shares Tank
-
Medifast, Inc. (MED) Tops Q3 EPS by 12c; Guides Above the Street
-
Medifast, Inc. (MED) Misses Q1 EPS by 8c
-
Medifast, Inc. (MED) Misses Q4 EPS by 13c; Issues Mixed Guidance
-
Medifast, Inc. (MED) Misses Q3 EPS by 1c, Sales Fall Short
-
Medifast, Inc. (MED) Misses Q2 EPS by 9c
Back to MED Stock Lookup